| Source Date | Board Meeting Date | Details |
|
02-Jul-2025
|
09-Jul-2025
|
Inter alia, to consider and approve the following businesses: 1. To consider and approve the appointment of Mr. Inesh Marwah as Non- executive Additional Director of the Company on the recommendation of Nomination and Remuneration Committee and Audit Committee. 2. To consider and approve the appointment of Mrs. Anu Marwah, Non- executive Director (DIN- 00645865) as Managing Director of the Company. 3. To re-constitute the various Committees of Board of Directors of the Company. 4. To discuss any other matter with the permission of the Board of Directors.
|
|
16-May-2025
|
22-May-2025
|
Inter alia, to consider and approve:- 1. To consider and approve the Standalone audited financial results of the Company for the quarter and year ended on 31st March, 2025 in accordance with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015. 2. To consider and approve the appointment of Internal Auditor for the financial year 2025-26. 3. To consider and approve the appointment of Secretarial Auditor for the financial year 2025-26. 4. To discuss any other matter with the permission of the Board of Directors.
|
|
13-Jan-2025
|
20-Jan-2025
|
Quarterly Results
|
|
17-Oct-2024
|
25-Oct-2024
|
Quarterly Results
|
|
23-Aug-2024
|
30-Aug-2024
|
Inter alia, to consider and approve:- 1. the Notice of the forthcoming 44th Annual General Meeting (AGM) of the Company along with Directors? Report thereon for the financial year ended March 31, 2024, and to fix the date and time of holding the AGM of the Company. 2. To consider the appointment/ re-appointment of Managing Director of the Company. 3. To appoint/ re-appoint Auditors and to fix their remuneration. 4. Any other matters with the permission of the Board.
|
|
15-Jul-2024
|
22-Jul-2024
|
Quarterly Results
|
|
16-May-2024
|
24-May-2024
|
Audited Results
|
|
29-Apr-2024
|
06-May-2024
|
Inter alia, to consider and approve the appointment of chief financial officer of the company
|
|
29-Jan-2024
|
08-Feb-2024
|
Quarterly Results
|
|
12-Oct-2023
|
20-Oct-2023
|
Quarterly Results
|
|
10-Jul-2023
|
20-Jul-2023
|
Quarterly Results
|
|
12-May-2023
|
18-May-2023
|
Inter alia, to consider and approve : 1. The appointment of Mr. Parminder Singh Kalsi (DIN-10152883) as an Additional Non-Executive Independent Director on the recommendation of Nomination and Remuneration Committee and Audit Committee. 2. the resignation of Mr. Vijay Kumar Nayar (DIN-08509514) Non-Executive Independent Director, from the Directorship of the Company. 3. To re-constitute the various Committees of Board of Directors of the Company. 4. Any other matter with permission of Board of Directors.
|
|
03-Apr-2023
|
11-Apr-2023
|
Audited Results
|
|
13-Jan-2023
|
23-Jan-2023
|
Quarterly Results
|
|
28-Oct-2022
|
04-Nov-2022
|
Quarterly Results
|
|
04-Aug-2022
|
12-Aug-2022
|
Quarterly Results
|
|
06-Apr-2022
|
14-Apr-2022
|
Audited Results
|
|
21-Mar-2022
|
28-Mar-2022
|
Inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 : 1. the appointment of Mr. Krishan Kant (DIN-08727674) as an Additional Non- Executive- Independent Director on the recommendation of Nomination and Remuneration Committee and Audit Committee. 2. To consider and approve the resignation of Mr. Sanjay Kumar Sareen, Independent Director, from the Directorship of the Company. 3. To discuss any other matter with the permission of the Board of Directors.
|
|
25-Jan-2022
|
04-Feb-2022
|
Quarterly Results & Inter alia, 2. To note and take on record the payment of Rs. 15 lacs made by the Company pursuant to Order no. WTM/AB/IVD/ID19/14250/2021-22 dated 23rd November, 2021 passed by the Securities Exchange Board of India imposing penalty and restraining the Company from accessing the securities market for a period of one year from the date of the Order. (Copy of the Order is attached). The payment was made on 6th January, 2022. 3. To discuss any other matter.
|
|
02-Nov-2021
|
10-Nov-2021
|
Quarterly Results
|